Yanfen Cui
Shanghai Jiao Tong University
9 Papers
48 Citations
Yanfen Cui is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Nasopharyngeal neoplasm & Medicine. The author has an hindex of 6, co-authored 9 publications. Previous affiliations of Yanfen Cui include Shanxi Medical University.
Chat about Author
Papers
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model
TL;DR: Molecular MRI of integrin αvβ3 expressed on activated HSCs by using RGD-USPIO may distinguish different liver fibrotic stages in CCl4 rat model and shows promising to noninvasively monitor the progression of the liver fibrosis and therapeutic response to antifibrotic treatment.
Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse.
Yanfen Cui,Caiyuan Zhang,Xiaoming Li,Huanhuan Liu,Bing Yin,Tian-Yong Xu,Yong Zhang,Dengbin Wang +7 more
TL;DR: This study supports that IVIM DWI is sensitive to detect the ZD6474-induced changes in NPC in nude mouse and the f parameter could predict early response to anti-angiogenic treatment.
Correlation between conventional MR imaging combined with diffusion-weighted imaging and histopathologic findings in eyes primarily enucleated for advanced retinoblastoma: a retrospective study.
Yanfen Cui,Yanfen Cui,Ran Luo,Ruifen Wang,Huanhuan Liu,Caiyuan Zhang,Zhongyang Zhang,Dengbin Wang +7 more
TL;DR: Conventional MRI has some limitations in reliably predicting microscopic infiltration, with the diagnostic efficiency showing room for improvement, whereas ADC values correlated well with certain high-risk prognostic parameters for retinoblastoma.
15
The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Yanfen Cui,Huanhuan Liu,Sheng Liang,Caiyuan Zhang,Weiwei Cheng,Wangxi Hai,Bing Yin,Dengbin Wang +7 more
TL;DR: 18F-AlF-NOTA-PRGD2 PET/CT can be used for in vivo angiogenesis imaging and monitoring early response to Endostar antiangiogenic treatment in NPC xenograft model, favoring its potential clinical translation.
Low contrast medium and radiation dose for hepatic computed tomography perfusion of rabbit VX2 tumor.
TL;DR: Compared with the conventional protocol, low contrast medium and radiation dose with iterative reconstruction has no significant influence on hepatic perfusion parameters for rabbits VX2 tumor.
6